BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3539631)

  • 1. Ambroxol decreases bronchial hyperreactivity.
    Melillo G; Cocco G
    Eur J Respir Dis; 1986 Nov; 69(5):316-20. PubMed ID: 3539631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the activity of ambroxol in children with aspecific bronchial hyperreactivity].
    Berni Canani M; De Luca L; Vuilleumier P; Berni Canani R
    Pediatr Med Chir; 1987; 9(3):327-31. PubMed ID: 3313296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical results in the treatment of chronic obstructive bronchitis with ambroxol in comparison with bromhexine (author's transl)].
    Wiessmann KJ; Niemeyer K
    Arzneimittelforschung; 1978; 28(5a):918-21. PubMed ID: 373777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antenatal use of ambroxol (bromhexine metabolite VIII) to prevent hyaline membrane disease: a controlled double-blind study.
    Wauer RR; Schmalisch G; Menzel K; Schröder M; Müller K; Tiller R; Methfessel G; Sitka U; Koepke E; Plath C; Schlegel C; Böttcher M; Köppe I; Fricke U; Severin K; Jacobi R; Schmidt W; Hinkel GK; Nitz I; Kunze D; Reichmann G; Lachmann B; Lampe K; Grauel EL
    Int J Biol Res Pregnancy; 1982; 3(2):84-91. PubMed ID: 7042592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambroxol therapy in simple chronic bronchitis: effects on subjective symptoms and ventilatory function.
    Ericsson CH; Juhász J; Jönsson E; Mossberg B
    Eur J Respir Dis; 1986 Oct; 69(4):248-55. PubMed ID: 3545883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of pirenzepine on bronchial reactivity evaluated by the methacholine provocation test in a double-blind study of patients with bronchial asthma].
    Rutkowski R; Siergiejko Z; Hofman J; Chyrek-Borowska S
    Pneumonol Pol; 1989; 57(10-12):477-81. PubMed ID: 2700385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of bronchial exocrine pathology after endobronchial treatment with ambroxol.
    Aliperta A; Bellissimo U; Turco D; Antinolfi G
    Int J Tissue React; 1986; 8(2):167-74. PubMed ID: 2939036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ambroxol in comparison with betamethasone for the stimulation of antepartal lung maturity. A clinical double-blind study].
    Vytiska-Binstorfer E; Salzer H; Simbruner G
    Zentralbl Gynakol; 1986; 108(4):220-9. PubMed ID: 3518290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possibility of interaction among antibiotics and mucolytics in children.
    Principi N; Zavattini G; Daniotti S
    Int J Clin Pharmacol Res; 1986; 6(5):369-72. PubMed ID: 3781700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambroxol for prophylaxis and treatment of bronchopulmonary complications after chest surgery.
    Romanini BM; Sandri MG; Tosi M; Mezzetti M; Mazzetti A
    Int J Clin Pharmacol Res; 1986; 6(2):123-7. PubMed ID: 3522443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of ambroxol to influence the allergen induced bronchial constriction in sensitized guinea pigs.
    Becher G; Winsel K; Barleben A
    Biomed Biochim Acta; 1989; 48(8):589-92. PubMed ID: 2619729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of ambroxol on tracheobronchial clearance in simple chronic bronchitis.
    Ericsson CH; Juhász J; Mossberg B; Philipson K; Svartengren M; Camner P
    Eur J Respir Dis; 1987 Mar; 70(3):163-70. PubMed ID: 3569448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril and bronchial reactivity.
    Sala H; Abad J; Juanmiquel L; Plans C; Ruiz J; Roig J; Morera J
    Postgrad Med J; 1986; 62 Suppl 1():76-7. PubMed ID: 3317334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modification of mucociliary clearance by a combination of theophylline with ambroxol and of ambroxol in monotherapy].
    Dorow P; Weiss T
    Arzneimittelforschung; 1988 Jun; 38(6):828-30. PubMed ID: 3052462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A controlled study on the action of a new formulation of ambroxol in asthmatiform bronchitis in children].
    Baldini G; Gucci M; Tarò D; Memmini C
    Minerva Pediatr; 1989 Feb; 41(2):91-5. PubMed ID: 2661989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of mucociliary transport in smokers by mucolytics.
    Olivieri D; Marsico SA; Del Donno M
    Eur J Respir Dis Suppl; 1985; 139():142-5. PubMed ID: 3862608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of ambroxol in the treatment of bronchial stasis. Clinical trial in 120 patients at two different doses.
    Germouty J; Jirou-Najou JL
    Respiration; 1987; 51 Suppl 1():37-41. PubMed ID: 3299566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between airway obstruction and bronchial hyperreactivity in childhood asthma.
    Galvez RA; McLaughlin FJ; Levison H
    Ann Allergy; 1987 Jan; 58(1):45-7. PubMed ID: 3541698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
    Norris V; Choong L; Tran D; Corden Z; Boyce M; Arshad H; Holgate S; O'Connor B; Millet S; Miller B; Rohatagi S; Kirkesseli S
    J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of lasolvan and bromhexine in chronic nonspecific lung diseases].
    Solopov VN; Lunichkina IV; Plisko LF
    Sov Med; 1989; (6):82-4. PubMed ID: 2678522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.